Home › Encyclopedia › BPC-157: Research Status, Identity, and Clinical Trials
Research / Unapproved

BPC-157: Research Status, Identity, and Clinical Trials

Molecular formulaC62H98N16O22
Molecular weight1419.5 g/mol
Registered trials4
PubChem CID9941957

Regulatory Status

BPC-157 is an unapproved research compound. It does not have an FDA-approved label, and no approved brand names, indications, or dosing information exist for it.

What BPC-157 Is

BPC-157 is a synthetic peptide with the molecular formula C62H98N16O22 and a molecular weight of approximately 1,419.5 g/mol. It is catalogued in PubChem under CID 9941957. Because no approved label exists, there is no established mechanism of action or drug class recognized by regulatory authorities for this compound.

Clinical Trial Activity

There are 4 registered clinical trials involving BPC-157. Among the trials on record, one Phase 2 study is recruiting participants to examine BPC-157 in the context of acute hamstring muscle strain repair. A separate Phase 1 study is listed as not yet recruiting and is designed to look at recovery following rotator cuff repair surgery. An earlier Phase 1 safety and pharmacokinetics trial (PCO-02) carries an unknown status. These registrations reflect ongoing or planned research activity and do not establish safety or effectiveness for any use.

FAQ

Is BPC-157 FDA-approved?
No. BPC-157 does not have an FDA-approved label, approved indications, or approved brand names. It is classified as an unapproved research compound.
What is BPC-157 made of?
BPC-157 is a synthetic peptide with the molecular formula C62H98N16O22 and a molecular weight of about 1,419.5 g/mol. It is listed in PubChem under CID 9941957.
Are there clinical trials studying BPC-157?
Yes, there are 4 registered clinical trials involving BPC-157. These include a Phase 2 trial recruiting for acute hamstring muscle strain repair and a Phase 1 trial examining recovery after rotator cuff repair surgery.
Does BPC-157 have known side effects?
There is no FDA Adverse Event Reporting System data currently available for BPC-157, so no reported side effect pattern can be summarized at this time.
What do the current trial statuses tell us about BPC-157?
The registered trials span different stages: one is recruiting, one is not yet recruiting, and one has an unknown status. This indicates research is ongoing but incomplete, and no conclusions about safety or effectiveness can be drawn yet.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 9941957 ClinicalTrials.gov

Updated 2026-11-07